Call for Abstracts

Poster and Short Talk Presentation GuidelinesAbstract Submission GuidelinesSubmit your abstract

The 2024 abstract submission is open.
Abstract submission will end on March 8 (midnight CET).

Before submitting your abstract, you must first register for the conference.
Please also read our Abstract Submission Guidelines.
Abstract presentation notifications will be sent after the review, at the beginning of April. We will post more information on this page in due time. Please regularly check your email inbox, including your spam folder.
________________________________________________________________________________
Abstract submission categories in 2024:

1. Improving Immunity: This session is for everyone whose research is focusedon inspiring, new strategies to enhance anti-tumor immune responses. 
2. Immunomonitoring: Tracking and characterizing immune responses is crucial to understanding how immune cells and tumors react to therapeutic interventions. Present your insights in this session.  
3. New Targets & New Leads: Present your poster in this session if you report on an exciting new target structure, or if you work on the development of innovative lead structures or therapeutic platforms.  
4. Cellular Therapies: From T-cell receptor therapy to chimeric antigen receptors – this session is all about cellular therapies, and not only restricted to T cells.  
5. Tumor Biology & Interaction with the Immune System:
 Choose this session if your aim is to unravel the complexity of the tumor microenvironment and to improve our understanding of the interaction between tumor and immune cells.  
6. Novel Tools & Technologies: Have you developed a new tool or technology, be it related to multiplexed imaging or single-cell transcriptomics? In this session, you can present the technology as well as the insights it enables. 

Review transparency:
Abstracts will be peer reviewed by a scientific committee. Abstracts will be rejected if they are out of scope of the meeting, i.e., not related to cancer immunology/immunotherapy, if they are purely commercial, or if scientific standards are obviously violated.

All accepted abstracts will be presented as posters during the meeting. From all accepted abstracts, authors of highly rated abstracts will be invited to deliver oral short talk presentations of their submitted work.

Request for withdrawal:
Once an abstract has been submitted, it may be withdrawn only by written request from the abstract presenter. The request may be sent to congress[at]cimt.eu and must be received at least 30 days prior to the start of the conference.

If an abstract is rejected for poster presentation, a full refund of the registration fee can be requested by contacting congress[at]cimt.eu. However, if your abstract is accepted but not selected for a short talk presentation, this policy does not apply.

Presenting your research at the CIMT Annual Meeting:
A remarkable one third of our delegates submit abstracts, and through a meticulous blind evaluation by our abstract review committee, 10% of all submissions are chosen for short talk presentation ensuring the most innovative and impactful research is showcased.

Our poster exhibit is a testament to the ingenuity and diligence of researchers from over 35 nations, providing a dynamic platform for the presentation of fresh, unpublished data and sparking inspiring dialogues during these lively sessions.

Early-career researchers are not only given a voice, but they are also celebrated—our poster awards, distributed in six categories, are determined by a dedicated prize committee who actively engage with the exhibits. Winning an award at the CIMT Annual Meeting is not just an honor; it's a potent career accelerator, spotlighting the awardees in a forum of
international repute and potential future collaborations.

Again in 2023, CIMT honored outstanding poster presentations of junior researchers with the CIMT Poster Awards.

CIMT 2023 Poster Awards

Six early-career researchers were chosen by the CIMT poster jury members to receive the 2023 CIMT Poster Awards supported by Immatics in six categories:

TUMOR BIOLOGY & INTERACTION WITH THE IMMUNE SYSTEM
Judit Díaz-Gómez
Vall d'Hebron Institute of Oncology (Barcelona, Spain)
2020
2019

Travel Awards

2024 Travel Awards

CIMT will offer travel stipends plus free conference admission to offset meeting-related expenses for researchers from Low, Lower-Middle, and Upper-Middle income countries as defined by the World Bank. Stipends can only be granted to researchers who have submitted an abstract.

Deadline for applications: March 28.

Jesus Junco Barranco (Cuba)
Monica Romero (Cuba)
Raanan Greenman (Israel)
Alper Kursune (Turkey)
Didem Özkazanc (Turkey)
Fortis Sotirios (Greece)
Annunziata Nigro (Italy)
Barbara Carreira (Portugal)
Liane Moura (Portugal)
Rita Acurcio (Portugal)
Quentin Lecocq (Belgium)
Vania Lo Presti (Netherlands)
Su Yin (Esther) Lim (Australia)
Travel awards application informationWorld Bank country list

Subscribe to the CIMT newsletter

Stay up to date on Europe’s largest meeting focused on cancer immunotherapy research and development